Sound Energy set to sell Morocco portfolio stake
Apax Global Alpha receive third quarter boost
South32 sell South African coal operations
Intu shares crash after income expectations fall
Xerox consider move to takeover HP
Mothercare descend into administration
Marks and Spencer’s profits plunge alerting crisis
London Stock Exchange opens North-American headquarters in Cleveland, Ohio
Elite Initiative
London Stock Exchange operates an international business-development initiative called Elite. Elite initiative helps small to medium-sized companies grow. Elite initiative has a successful history of helping small and medium-companies generate growth around the world. For example, Elite helps businesses expand their reach by providing training and networking opportunities. It connects businesses with investors as well as business consultants. Elite’s network has more than 1,200 businesses and investors across 43 countries around the world. London Stock Exchange Group announced that it will open its North American headquarters for the Elite initiative in Cleveland, Ohio. London Stock Exchange Group will start operating its Cleveland headquarters by the start of next year.Cleveland, Ohio
Cleveland is one of the investment hubs of the United States. It is home to important cultural, educational and financial institutions. Furthermore, Cleveland has a growing housing market as more and more professionals move to the city for work. Elite initiative will hire an additional 40 employees with an annual payroll of $5 million. Moreover, Cleveland expects positive annual growth amid London Stock Exchange’s decision to open its headquarters in the city. The benefits of opening headquarters in Cleveland extend beyond the direct employment effect.Global Connection
Elite initiative will build a global connection between Cleveland and the rest of the world by facilitating Cleveland’s access to capital. Moreover, Elite Initiative’s international conference on business development will take place in Cleveland next year. Elite Initiative has never hosted the conference outside of Europe in the past. London Stock Exchange collaborated with JobsOhio, an economic development nonprofit to facilitate the expansion of its business in Northern America.Growth Potential
Cleveland is home to many small and medium-sized enterprises, making the city an ideal location for London Stock Exchange. Furthermore, Cleveland has a long history of institutional investment. Additionally, Cleveland has multiple prestigious universities that are famous for their business programs. Hence, London Stock Exchange recognizes Cleveland’s growth potential in finance, business development and banking.A dull Tuesday for currencies and indices
“The markets didn’t have that much in them this Tuesday, trading predicated on the vestiges of Monday’s surge of trade optimism.”
“No index really stood out as the day went. The FTSE’s 0.4% increase placed it at the front of the pack, its mining stocks doing a lot of the heavy lifting”
Today in the mining sector, ARC Minerals Ltd (LON: ARCM) uncovered further copper assays, Lucara Diamond Corp (TSE: LUC) was pessimistic in its revenue guidance and MC Mining (LON: MCM) was granted a coal mining right in South Africa.“[However], that still leaves the UK index short of 7400, and lacking the multi-year/all-time highs struck by its peers.”
“The DAX held above 13130 and not much else, struggling to find a reason to build on yesterday’s near-17 month peak. The CAC, meanwhile, shuffled to a fresh 12-year high of 5840 after adding 20 points.”
“Closing Monday at an all-time best, the Dow Jones decided to put up its feet on Tuesday. The US index could only muster a 0.1% increase, keeping it from hitting 27500. It may need to wait for another trade deal update if it is to make any further serious strides.”
“In one of the more notable elements of Tuesday’s trading, investors started offloading their euros, sending the single currency down half a percent against the dollar and 0.4% against the pound (sending sterling back above €1.1622).”
Amryt Pharma boasts 20% year-to-date revenue bounce
This led to a total take of $113.1 million in Company revenues for the year-to-date, up 19.7%.
The Company added that it is deploying its proven Lojuxta strategy in Europe to reinvigorate it Juxtapid business in the US market. It also said that the integration of Aegerion was underway, and that relocation of non-customer facing roles from Boston to Dublin were on track.Amryt comments
Dr Joe Wiley, CEO, stated,
“The first nine months of 2019 have been momentous and transformational for Amryt. Through the acquisition of Aegerion, we have evolved from a company with a single asset on the market in EMEA to become a global biopharmaceutical company with two orphan disease products and a commercial infrastructure across North America, EMEA and LATAM.”
“For the nine-month period to 30 September 2019, pro-forma revenues of the combined company have grown by 19.7% compared with the same period in 2018. Myalept has continued to grow in the US where the product is approved for Generalized Lipodystrophy, and we are now in the active launch-phase of Myalepta in EMEA, where this product is approved for both Generalized and Partial Lipodystrophy. It has been pleasing to see Lojuxta continue to deliver revenue growth and we are now implementing in the US a similar strategy to that used to significantly grow Lojuxta in Europe.”
“Looking to our pipeline, our late stage development asset, AP101, for the treatment of wound-related complications in EB, continues to enrol patients in the Phase 3 study following the encouraging outcome of interim safety and efficacy analyses conducted by the Independent Data Monitoring Committee. The study is on track to be fully enrolled in the coming months.”
“Amryt is now very well positioned to execute on our strategy of becoming a global leader in the rare and orphan disease space and most importantly, delivering therapies to patients with unmet needs.”
